Access cutting-edge retroperitoneal sarcoma treatment through this clinical trial at a research site in Emory. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Emory location
Preparing your pre-screening questions…
Access retroperitoneal sarcoma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related retroperitoneal sarcoma treatment provided free
Check if you qualify for this retroperitoneal sarcoma clinical trial in Emory, GA
No-Cost Study Care
Local to Emory
Convenient for GA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Surgery is currently the only potentially curative treatment modality for localized retroperitoneal sarcoma (RPS). Available studies regarding oncologic outcomes are mainly retrospective in nature, and RPS are recognized as a rare disease. Therefore, prospective analysis of high quality data is a top priority. Primary Objectives of this study are: * to prospectively collect standardized clinical data and radiological and pathological material from primary RPS patients treated with surgery at reference centers. * patient outcome will be evaluated in terms of overall survival (OS), disease-free survival (DFS), crude cumulative incidence (CCI) of local recurrence (LR) and distant metastasis (DM). Secondary Objectives: * to estimate the efficacy and safety of surgical treatment, including extended surgical approach to primary RPS; * to prospectively evaluate the impact of multimodality therapy, including radiation therapy and chemotherapy; * to identify clinical, radiological and pathological characteristics that may influence the oncological outcome or may be used as predictors of LR/DM/OS. These may be important biomarkers of disease; * to utilize collected pathological material for research collaborations.
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Yes, this clinical trial (NCT03838718) has an active research site in Emory, GA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for retroperitoneal sarcoma treatment options in Emory, GA, this clinical trial (NCT03838718) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Emory research site is actively enrolling participants for this clinical trial. You'll receive care from experienced retroperitoneal sarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all retroperitoneal sarcoma clinical trials near you to find additional studies recruiting in your area.
See all sarcoma clinical trials recruiting in Emory — not just this study.
Browse Sarcoma Trials in Emory →